Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn More
To improve patient care, innovation and outcomes at better value for the health system we enable projects and programmes to take place from which each stakeholder is able to derive mutual benefit. This is achieved via a transparent platform of partnership and cooperation between industry and the NHS, both nationally and regionally.
In 2017, IQVIA entered into a strategic collaboration with the country’s leading transformative body for oncology services, the national Cancer Vanguard. The Cancer Vanguard works across a total population of 10.7 million people, providing an unprecedented opportunity to transform and create new models of cancer care that can be reproduced nationally. This initiative, in partnership with the pharmaceutical industry, has recently been extended to improve the breast cancer patient care pathway across the Greater Manchester and represents a clear embodiment of a core pillar of the life sciences industrial strategy in using data and digital tools to support research and improve patient care.
Gain crucial insight into quality of care and deliver rapid improvements.
To know more about how IQVIA can aid the collection of patient reported outcome measures, patient experience and clinical audit data.
